Cian Healthcare Ltd

Cian Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Cian Healthcare Ltd

₹ 3.18 0.95%
17 Apr - close price
cian.co BSE - SME: 542678
About

Incorporated in 2003, Cian Healthcare Ltd is engaged in manufacturing and marketing of pharmaceutical products.[1]

Key Points

Business Overview:[1][2]
CHI is a fully integrated pharmaceutical company dealing in gynecology, hematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, vitamins & nutrient products.

Website BSE
  • Market Cap ₹ 7.95 Cr.
  • Current Price ₹ 3.18
  • High / Low ₹ 26.5 / 2.97
  • Stock P/E
  • Book Value ₹ 18.5
  • Dividend Yield 0.00 %
  • ROCE 4.77 %
  • ROE 0.63 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.17 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -1.21% over past five years.
  • Promoter holding is low: 27.1%
  • Company has a low return on equity of -0.42% over last 3 years.
  • Promoters have pledged 34.5% of their holding.
  • Promoter holding has decreased over last 3 years: -43.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Sep 2019 Mar 2020 Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024
30 29 28 39 34 37 27 35 33 31 28 19
30 26 23 34 29 36 24 32 28 28 23 19
Operating Profit -0 3 4 5 5 1 3 3 5 2 5 -0
OPM % -1% 11% 16% 12% 14% 4% 13% 9% 16% 7% 18% -0%
1 0 1 -0 0 0 0 0 0 1 0 -12
Interest 3 3 3 3 3 3 2 2 2 2 2 2
Depreciation 2 2 1 1 1 1 1 2 2 2 2 2
Profit before tax -4 -1 1 1 0 -2 0 -1 2 -1 1 -16
Tax % -26% 0% 12% 35% 140% -0% -48% 22% 7% -23% 0%
-3 -1 1 0 -0 -2 0 -0 1 -1 1 -16
EPS in Rs -1.76 -0.51 0.48 0.16 -0.02 -1.01 0.04 -0.11 0.54 -0.49 0.57 -6.21
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
14 23 31 47 52 66 62 57 72 64 68 59 47
13 19 26 39 42 53 55 49 63 59 58 51 42
Operating Profit 1 4 5 8 10 13 8 8 10 5 9 8 5
OPM % 10% 16% 16% 16% 20% 20% 13% 14% 13% 8% 13% 13% 11%
0 0 0 0 0 0 1 1 0 0 1 1 -12
Interest 0 1 1 4 5 6 6 6 6 5 5 5 4
Depreciation 0 0 1 2 2 2 2 2 2 3 4 4 3
Profit before tax 1 2 3 2 3 5 1 0 1 -2 1 0 -14
Tax % 32% 32% 32% 29% 25% 24% 31% 188% 51% -4% 10% -3,800%
1 2 2 2 2 4 1 -0 0 -2 1 0 -14
EPS in Rs 250.00 154.00 186.00 110.71 165.00 285.71 0.38 -0.03 0.14 -0.91 0.43 0.16 -5.64
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 10%
5 Years: -1%
3 Years: -7%
TTM: -26%
Compounded Profit Growth
10 Years: -13%
5 Years: -11%
3 Years: -2%
TTM: -1669%
Stock Price CAGR
10 Years: %
5 Years: -33%
3 Years: -48%
1 Year: -85%
Return on Equity
10 Years: 3%
5 Years: 0%
3 Years: 0%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.40 1 1 1 1 1 17 23 23 25 25 25 25
Reserves 3 5 7 10 12 16 5 36 37 35 36 37 21
9 16 32 31 40 50 49 51 49 43 43 41 39
4 4 6 15 8 8 22 24 25 36 36 40 42
Total Liabilities 17 26 46 57 61 77 92 135 135 140 141 143 128
1 2 19 18 21 20 23 21 19 33 29 26 24
CWIP 7 10 5 5 4 7 6 25 26 13 14 15 15
Investments 0 0 0 0 0 0 0 7 7 7 7 7 7
8 14 22 33 36 50 62 82 83 87 90 95 81
Total Assets 17 26 46 57 61 77 92 135 135 140 141 143 128

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0 0 0 10 6 8 13 -9 5 6 2 7
0 0 0 -5 -4 -3 -8 -25 -1 -4 -1 -1
0 0 0 -5 -2 -6 -3 35 -5 -3 -1 -6
Net Cash Flow 0 0 0 0 0 -0 2 1 -1 -1 -0 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 79 121 116 95 97 142 130 128 93 104 127 114
Inventory Days 169 159 137 128 160 144 267 260 325 310 404
Days Payable 60 71 122 21 53 144 217 179 275 211 270
Cash Conversion Cycle 79 230 204 111 204 249 130 178 175 154 227 248
Working Capital Days 125 159 165 108 165 199 158 142 121 192 210 209
ROCE % 16% 20% 14% 15% 17% 18% 9% 7% 7% 3% 6% 5%

Shareholding Pattern

Numbers in percentages

9 Recently
Mar 2021Sep 2021Dec 2021Mar 2022Sep 2022Dec 2022Mar 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025
70.89% 70.89% 66.26% 66.26% 66.26% 66.26% 51.85% 49.62% 27.10% 27.10% 27.11% 27.11%
0.00% 0.00% 0.00% 0.00% 0.00% 0.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
29.11% 29.11% 33.74% 33.74% 33.75% 32.96% 48.16% 50.39% 72.90% 72.90% 72.90% 72.89%
No. of Shareholders 3613853963924244184546728808311,0881,501

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings